Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 46 Records) |
| Query Trace: Neoplasms and CYP2B6[original query] |
|---|
| CYP2B6*6 is associated with increased breast cancer risk. International journal of cancer. Journal international du cancer 2014 Jan 134 (2): 426-30. Justenhoven Christina, Pentimalli Daniela, Rabstein Sylvia, Harth Volker, Lotz Anne, Pesch Beate, Brüning Thomas, Dörk Thilo, Schürmann Peter, Bogdanova Natalia, Park-Simon Tjoung-Won, Couch Fergus J, Olson Janet E, Fasching Peter A, Beckmann Matthias W, Häberle Lothar, Ekici Arif, Hall Per, Czene Kamilla, Liu Janjun, Li Jingmei, Baisch Christian, Hamann Ute, Ko Yon-Dschun, Brauch Hiltr |
| Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. International journal of molecular sciences 2013 14 (4): 8381-92. Wassenaar Catherine A, Dong Qiong, Amos Christopher I, Spitz Margaret R, Tyndale Rachel |
| Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil. Cancer chemotherapy and pharmacology 2014 Oct 74 (4): 667-74. Jamieson David, Lee Jo, Cresti Nicola, Jackson Rosanna, Griffin Melanie, Sludden Julieanne, Verrill Mark, Boddy Alan |
| Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy. Clinica chimica acta; international journal of clinical chemistry 2014 Jul 434 21-8. Tulsyan Sonam, Agarwal Gaurav, Lal Punita, Mittal Balr |
| Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy. Cancer chemotherapy and pharmacology 2014 Jun 73 (6): 1181-8. Mwinyi Jessica, Vokinger Kerstin, Jetter Alexander, Breitenstein Urs, Hiller Christian, Kullak-Ublick Gerd A, Trojan Andre |
| Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer. Cancer chemotherapy and pharmacology 2015 Jan 75 (1): 207-14. Haroun F, Al-Shaar L, Habib R H, El-Saghir N, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, Cascorbi I, Zgheib N |
| Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy. International journal of clinical pharmacology and therapeutics 2015 Sep . Zhou Xinna, Wang Xiaoli, Song Qingkun, Yang Huabing, Zhu Xishan, Yu Jing, Song Guohong, Di Lijun, Ren Jun, Shao Hong, Lyerly Herbert K |
| Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers. Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
| The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa. Scientific reports 2015 5 16775. Song Qingkun, Zhou Xinna, Yu Jing, Dong Ningning, Wang Xiaoli, Yang Huabing, Ren Jun, Kim Lyerly |
| Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study. Medicine 2016 Nov 95 (44): e5151. Tsuji Daiki, Ikeda Midori, Yamamoto Keisuke, Nakamori Harumi, Kim Yong-Il, Kawasaki Yohei, Otake Aki, Yokoi Mari, Inoue Kazuyuki, Hirai Keita, Nakamichi Hidenori, Tokou Umi, Shiokawa Mitsuru, Itoh Kunihi |
| Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer. Oncotarget 2017 Feb . Kuo Sung-Hsin, Yang Shi-Yi, You San-Lin, Lien Huang-Chun, Lin Ching-Hung, Lin Po-Han, Huang Chiun-She |
| Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer. Oncotarget 2017 Nov 8 (59): 100296-100311. Woo Hye In, Lee Se Kyung, Kim Jiyoung, Kim Seok Won, Yu Jonghan, Bae Soo Youn, Lee Jeong Eon, Nam Seok Jin, Lee Soo-Yo |
| Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients. European journal of clinical pharmacology 2018 Jul . Tanaka Hironari, Naito Takafumi, Sato Hikaru, Hiraide Takanori, Yamada Yasuhide, Kawakami Junic |
| Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2019 May . Paula Daniela Polessa, do Brasil Costa Vanessa I, Jorge Rosane V, Nobre Flávio |
| CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2019 5 10 481. Ahmed Jemal Hussien, Makonnen Eyasu, Yimer Getnet, Seifu Daniel, Bekele Abebe, Assefa Mathewos, Aseffa Abraham, Howe Rawleigh, Fotoohi Alan, Hassan Moustapha, Aklillu Ele |
| Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study. Clinical pharmacology and therapeutics 2019 Feb . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Suc Etienne, Sillet-Bach Isabelle, Filleron Thomas, Roché Henri, Chatelut Etienne, White-Koning Melanie, Thomas Fabien |
| Severe and prolonged cyclophosphamide-induced hepatotoxicity in a breast cancer patient carrying a CYP2B6*7 variant. Pharmacogenomics 2019 11 20 (16): 1119-1124. Ming Zhao, Yongqiang Zhang, Zijin Zhang, Yan Xu, Di Chen, Xiaoxin Ti |
| Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial. Journal of translational medicine 2019 10 17 (1): 328. Alunni-Fabbroni Marianna, Rönsch Kerstin, Huber Thomas, Cyran Clemens C, Seidensticker Max, Mayerle Julia, Pech Maciej, Basu Bristi, Verslype Chris, Benckert Julia, Malfertheiner Peter, Ricke Je |
| Genetic Polymorphism of GSTP-1 Affects Cyclophosphamide Treatment of Autoimmune Diseases. Molecules (Basel, Switzerland) 2020 4 25 (7): . Hajdinák Péter, Szabó Melinda, Kiss Emese, Veress Lili, Wunderlich Lívius, Szarka Andr |
| Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer. Clinical pharmacology and therapeutics 2020 Oct . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Dohollou Nadine, Bernard-Marty Chantal, Laharie-Mineur Hortense, Filleron Thomas, Roché Henri, Chatelut Etienne, Thomas Fabienne, White-Koning Melan |
| Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients. Aging 2021 6 13 (12): 16316-16340. Liu Yang, Zhou Jia-Wei, Liu Cun-Dong, Yang Jian-Kun, Liao De-Ying, Liang Zhi-Jian, Xie Xiao, Zhou Qi-Zhao, Xue Kang-Yi, Guo Wen-Bing, Xia Ming, Zhou Jun-Hao, Bao Ji-Ming, Yang Cheng, Duan Hai-Feng, Wang Hong-Yi, Huang Zhi-Peng, Zhao Shan-Chao, Chen Ming-K |
| Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients. Cancer chemotherapy and pharmacology 2021 Jun . Helsby Nuala, Yong Minghan, Burns Kathryn, Findlay Michael, Porter Dav |
| Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population. Pharmaceuticals (Basel, Switzerland) 2021 4 14 (3): . Barnett Shelby, Errington Julie, Sludden Julieann, Jamieson David, Poinsignon Vianney, Paci Angelo, Veal Gareth |
| Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 12 112 (5): 1165-1176. Li Li, Tang Shanshan, Yin Jiani C, Dong Lihua, Yang Zhe, Liu Yueping, Ma Jie, Chang Pengyu, Pang Jiaohui, Bao Hua, Mu Dianbin, Zheng Xiaoli, Aishajiang Reyida, He Kewen, Zhang Shaotong, Ni Meng, Wu Xue, Wang Xiaonan, Shao Yang, Wang Jun, Ge Hong, Yu Jinming, Yuan Shuang |
| Pharmacogenetics of the cytochromes P450: Selected pharmacological and toxicological aspects. Advances in pharmacology (San Diego, Calif.) 2022 8 95 49-72. Daly Ann |
| Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 May . Hwang Mary, Medley Sarah, Shakeel Faisal, Vanderwerff Brett, Zawistowski Matthew, Kidwell Kelley M, Hertz Daniel |
| Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics 2022 Feb 14 (2): . Sendra Luis, Olivera Gladys G, López-Andújar Rafael, Serrano Cristina, Rojas Luis E, Montalvá Eva María, Herrero María José, Aliño Salvador |
| Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 Oct . Perez-Paramo Yadira X, Watson Christy J W, Chen Gang, Thomas Claire E, Adams-Haduch Jennifer, Wang Renwei, Khor Chiea Chuen, Koh Woon-Puay, Nelson Heather H, Yuan Jian-Min, Lazarus Phil |
| Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers 2023 3 15 (5): . Urtasun Andrea, Olivera Gladys G, Sendra Luis, Aliño Salvador F, Berlanga Pablo, Gargallo Pablo, Hervás David, Balaguer Julia, Juan-Ribelles Antonio, Andrés María Del Mar, Cañete Adela, Herrero María Jo |
| Genetic polymorphisms in CYP2B6 may be associated with lung cancer risk in the Chinese Han population. Expert review of respiratory medicine 2024 1 1-9. Xiaoya Ma, Xufeng Zang, Leteng Yang, Wenqian Zhou, Yujie Li, Jie Wei, Jinping Guo, Junhui Han, Jing Liang, Tianbo J |
- Page last reviewed:Feb 1, 2024
- Content source: